Biologics targeting IL-23 in moderate-to-severe psoriasis: lessons learned from real-world use
{{output}}
Introduction: Psoriasis is a chronic, systemic inflammatory disease with significant physical and psychosocial burden. Advances in understanding the pathogenesis of psoriasis, particularly the role of interleukin (IL)23/Th17 axis... ...
